The University of Virginia Licensing and Ventures Group Seed Fund has made its fourth investment, putting an undisclosed sum into 510 Kardiac Devices.
510 Kardiac Devices, a US-based medical devices spinout from University of Virginia (UVA) Health System, raised seed funding today from investors including the UVA Licensing and Ventures Group (LVG) Seed Fund.
The round was also supported by medical design and manufacturing company Nextern Medical.
Founded in 2015, 510 Kardiac Devices is developing a medical device, called Lim Transseptal System (LTS), for cardiovascular surgical procedures. LTS enables surgeons to precisely target specific locations within the structures of the heart.
The company…
